Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
82 studies found for:    Alzheimer's disease | United States, Tennessee
Show Display Options
Rank Status Study
1 Unknown  Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: donepezil
2 Recruiting A Study of RO7105705 in Healthy Participants and Participants With Mild-to-Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Placebo;   Drug: RO7105705
3 Completed Testing the Effectiveness of Telephone Support for Dementia Caregivers
Conditions: Dementia;   Alzheimer Disease
Intervention: Behavioral: Telephone Support
4 Completed PACT: Providers and Alzheimer's Caregivers Together
Conditions: Alzheimer's Disease;   Dementia
Intervention: Behavioral: Skills Building for Caregiver Health and Care-recipient
5 Recruiting Inherited Diseases, Caregiving, and Social Networks
Conditions: Alzheimer's Disease;   Inborn Errors of Metabolism;   Mitochondrial Disorders;   Undiagnosed Diseases
Intervention:
6 Terminated A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Bapineuzumab
7 Unknown  Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
Condition: Alzheimer Disease
Interventions: Drug: alphatocopherol;   Drug: Selenium;   Drug: Placebo replacement for vitamin E;   Drug: Placebo replacement for Selenium
8 Recruiting 221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Aducanumab (BIIB037);   Drug: Placebo
9 Completed Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)
Condition: Alzheimer's Disease
Interventions: Drug: Bapineuzumab 0.5 mg/kg;   Drug: Placebo Control;   Drug: Bapineuzumab 1.0 m/kg
10 Completed Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)
Condition: Alzheimer's Disease
Interventions: Drug: Bapineuzumab 0.5 mg/kg;   Drug: Placebo Control;   Drug: Bapineuzumab 1.0 m/kg
11 Completed
Has Results
A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Dimebon;   Drug: Placebo
12 Recruiting Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)
Condition: Alzheimer's Disease
Interventions: Drug: Piromelatine;   Drug: Placebo
13 Recruiting Evaluation of the Efficacy and Safety of Azeliragon (TTP488) in Patients With Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Azeliragon;   Drug: Placebo
14 Completed Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: TRx0237 200 mg/day;   Drug: Placebo
15 Active, not recruiting Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Condition: Alzheimer's Disease
Interventions: Drug: Solanezumab;   Drug: Placebo
16 Completed Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Rosiglitazone
17 Terminated A Randomized Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: FK962
18 Completed Coordinating Center for Enhancing ADRD Caregiving
Conditions: Dementia;   Alzheimer Disease
Interventions: Procedure: Skill Training Condition – problem solving training;   Procedure: REACH for TLC (Telephone Linked Computer) system
19 Terminated
Has Results
An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Dimebon
20 Active, not recruiting AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
Condition: Alzheimer's Disease
Interventions: Drug: AC-1204;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.